5-Allyl-2-hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide

Catalog No. :
ACDSEY675
CAS No. :
26750-81-2
Molecular Formula :
C13H17NO4
Molecular Weight :
251.28

IUPAC Name:5-allyl-2-hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide

5-Allyl-2-hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$89.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Allyl-2-hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide
IUPAC Name5-allyl-2-hydroxy-N-(2-hydroxyethyl)-3-methoxybenzamide
MDL No.MFCD00865165
Molecular FormulaC13H17NO4
Molecular Weight251.28
SMILESO=C(NCCO)C1=CC(CC=C)=CC(OC)=C1O
InChI KeyUMJHTFHIQDEGKB-UHFFFAOYSA-N
SynonymALIBENDOL [WHO-DD] | Hydroxy-2 methoxy-3 allyl-5 N-(beta-hydroxy ethyl)benzamide | SW219612-1 | AB01566848_01 | Tox21_112247_1 | H-3774 | AKOS015894906 | cebera | CHEBI:135023 | HMS3884I16 | Hydroxy-2 methoxy-3 allyl-5 N-(beta-hydroxy ethyl)benzamide [Fre
CAS No.26750-81-2
PubChem CID71916

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDSEY675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6 In Stock
  4. Then
  5. ACDSEY675 route product structure diagram
    ACDSEY67526750-81-2 In Stock
Inquiry

2. ACDSEY675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUZDF205 route compound structure diagram
    ACUZDF20585614-43-3 In Stock
  2. Plus
  3. ACKTWL140 route compound structure diagram
    ACKTWL1402002-24-6 In Stock
  4. Then
  5. ACDSEY675 route product structure diagram
    ACDSEY67526750-81-2 In Stock
Inquiry

Comments (0)